Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 185 participants.
Also called NCT01652001
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 185 participants
- Registry
-
NCT01652001
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01652001. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2014-01 (actual). Results posted on 2016-04-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
- Condition
- Xerostomia
- Condition
- Depression
- Condition
- Hypertension
- Intervention (Drug)
- Malic Acid
- Intervention (Other)
- Placebo
- Lead sponsor
- Universidad de Granada
- Collaborator
- Instituto de Salud Carlos III
Record details
- Record id
cardio:ct-nct01652001- Content hash
37a1bf8ca5236b2da0aa1adbc5d9261798d69ac7c85356dae71eec4b4889a09a